Are you an EPFL student looking for a semester project?
Work with us on data science and visualisation projects, and deploy your project as an app on top of Graph Search.
Concept
Plasmapheresis
Summary
Plasmapheresis (from the Greek πλάσμα, plasma, something molded, and ἀφαίρεσις aphairesis, taking away) is the removal, treatment, and return or exchange of blood plasma or components thereof from and to the blood circulation. It is thus an extracorporeal therapy, a medical procedure performed outside the body.
Three general types of plasmapheresis can be distinguished:
Autologuous, removing blood plasma, treating it in some way, and returning it to the same person, as a therapy.
Exchange, a patient's blood plasma is removed, while blood products are given in replacement. This type is called plasma exchange (PE, PLEX, or PEX) or plasma exchange therapy (PET). The removed plasma is discarded and the patient receives replacement donor plasma, albumin, or a combination of albumin and saline (usually 70% albumin and 30% saline).
Donation, removing blood plasma, separating its components, and returning some of them to the same person, while holding out others to become blood products that this person donates for those in need. In such a plasma donation procedure, blood is removed from the body, blood cells and plasma are separated, and the blood cells are returned, while the plasma is collected and frozen to preserve it for eventual use as fresh frozen plasma or as an ingredient in the manufacture of blood products.
Plasmapheresis of the autologous and exchange types is used to treat a variety of disorders, including those of the immune system, such as Goodpasture's syndrome, Guillain–Barré syndrome, lupus, myasthenia gravis, and thrombotic thrombocytopenic purpura.
During plasmapheresis, blood, which consists of blood cells and a clear liquid called blood plasma, is initially taken out of the body through a needle or previously implanted catheter. Plasma is then removed from the blood by a cell separator. Three procedures are commonly used to separate the plasma from the blood cells, with each method having its own advantages and disadvantages:
Discontinuous flow centrifugation: One venous catheter line is required.
Official source
About this result
This page is automatically generated and may contain information that is not correct, complete, up-to-date, or relevant to your search query. The same applies to every other page on this website. Please make sure to verify the information with EPFL's official sources.
Ontological neighbourhood
Related courses (1)
PHYS-325: Introduction to plasma physics
Introduction à la physique des plasmas destinée à donner une vue globale des propriétés essentielles et uniques d'un plasma et à présenter les approches couramment utilisées pour modéliser son comport
Related lectures (6)
MHD Equilibrium & Stability
Explores Magnetohydrodynamic equilibrium and stability, ideal MHD solutions, 'hairy ball' theorem, and boundary conditions.
Sedimentation: Blood Plasma Separation in Microfluidics
Covers the sedimentation speed of particles and cells, blood plasma separation, and size-selective trapping in microfluidics.
Market Mechanisms: Crowdfunding, Prediction Markets, Quadratic Voting
Explores crowdfunding, prediction markets, and quadratic voting as market-based mechanisms.
Related publications (22)
Equilibrium pressure limits in stellarators
This thesis delves into the potential of magnetic fusion energy, and in particular focuses on the stellarator concept. Stellarators use external coils to produce 3-dimensional (3D) magnetic fields that confine a thermonuclear plasma in a topologically toro ...
EPFL2023Microfluidic characterisation reveals broad range of SARS-CoV-2 antibody affinity in human plasma
Didier Trono, Priscilla Turelli, Marc Emmenegger
The clinical outcome of SARS-CoV-2 infections, which can range from asymptomatic to lethal, is crucially shaped by the concentration of antiviral antibodies and by their affinity to their targets. However, the affinity of polyclonal antibody responses in p ...
LIFE SCIENCE ALLIANCE LLC2022Programmable DARPin-based receptors for the detection of thrombotic markers
Leo Scheller, Yujia Wang, Haifeng Ye
Cellular therapies remain constrained by the limited availability of sensors for disease markers. Here we present an integrated target-to-receptor pipeline for constructing a customizable advanced modular bispecific extracellular receptor (AMBER) that comb ...
NATURE PORTFOLIO2022Related people (3)
Related concepts (17)
Rituximab
Rituximab, sold under the brand name Rituxan among others, is a monoclonal antibody medication used to treat certain autoimmune diseases and types of cancer. It is used for non-Hodgkin lymphoma, chronic lymphocytic leukemia (in non-geriatric patients), rheumatoid arthritis, granulomatosis with polyangiitis, idiopathic thrombocytopenic purpura, pemphigus vulgaris, myasthenia gravis and Epstein–Barr virus-positive mucocutaneous ulcers. It is given by slow injection into a vein.
Apheresis
Apheresis (ἀφαίρεσις (aphairesis, "a taking away")) is a medical technology in which the blood of a person is passed through an apparatus that separates out one particular constituent and returns the remainder to the circulation. It is thus an extracorporeal therapy. One of the uses of apheresis is for collecting stem cells. Depending on the substance that is being removed, different processes are employed in apheresis. If separation by density is required, centrifugation is the most common method.
Thrombotic thrombocytopenic purpura
Thrombotic thrombocytopenic purpura (TTP) is a blood disorder that results in blood clots forming in small blood vessels throughout the body. This results in a low platelet count, low red blood cells due to their breakdown, and often kidney, heart, and brain dysfunction. Symptoms may include large bruises, fever, weakness, shortness of breath, confusion, and headache. Repeated episodes may occur. In about half of cases a trigger is identified, while in the remainder the cause remains unknown.